Lewen R, Insler M S
Ann Ophthalmol. 1985 May;17(5):315-8.
Sixteen consecutive patients undergoing primary posterior chamber lens insertion with Healon were followed closely for any postoperative rise in intraocular pressure. Patients were divided into an experimental group (who received acetazolamide) and a control group (no acetazolamide). Careful attention was given to the same operative technique and the amount of Healon left in the eye. The treated group showed a mean intraocular pressure of 14.7 mm Hg, whereas the pressure in the control group was 22.6 mm Hg on the first postoperative day. These findings support the rationale for the use of prophylactic acetazolamide as an adjunct to Healon-aided cataract surgery.
连续16例接受Healon辅助的后房型人工晶状体植入术的患者被密切随访术后眼压的任何升高情况。患者被分为实验组（接受乙酰唑胺）和对照组（未接受乙酰唑胺）。对相同的手术技术以及眼内残留的Healon量给予了仔细关注。治疗组术后第一天的平均眼压为14.7毫米汞柱，而对照组的眼压为22.6毫米汞柱。这些发现支持了将预防性乙酰唑胺用作Healon辅助白内障手术辅助药物的理论依据。
